Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 64 articles:
HTML format



Single Articles


    June 2022
  1. MAKINO Y, Hikita H, Fukumoto K, Sung JH, et al
    Constitutive activation of the tumor suppressor p53 in hepatocytes paradoxically promotes non-cell autonomous liver carcinogenesis.
    Cancer Res. 2022 Jun 13. pii: 704882. doi: 10.1158/0008-5472.CAN-21-4390.
    PubMed     Abstract available


    May 2022
  2. HEINZ MC, Peters NA, Oost KC, Lindeboom RGH, et al
    Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage.
    Cancer Res. 2022;82:1953-1968.
    PubMed     Abstract available


  3. LIU Z, Ye Y, Liu Y, Liu Y, et al
    RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1.
    Cancer Res. 2022;82:1937-1952.
    PubMed     Abstract available


    April 2022
  4. CHENG Y, Bai F, Ren X, Sun R, et al
    Phosphoinositide-Binding Protein TIPE1 Promotes Alternative Activation of Macrophages and Tumor Progression via PIP3/Akt/TGFbeta Axis.
    Cancer Res. 2022;82:1603-1616.
    PubMed     Abstract available


  5. BAYARD Q, Cordier P, Peneau C, Imbeaud S, et al
    Structure, Dynamics, and Impact of Replication Stress-Induced Structural Variants in Hepatocellular Carcinoma.
    Cancer Res. 2022 Apr 8:OF1-OF12. doi: 10.1158/0008-5472.CAN-21-3665.
    PubMed     Abstract available


    January 2022
  6. LI J, Hu ZQ, Yu S, Mao L, et al
    CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma.
    Cancer Res. 2022 Jan 19. pii: 0008-5472.CAN-21-1259.
    PubMed     Abstract available


  7. ADACHI Y, Kamiyama H, Ichikawa K, Fukushima S, et al
    Inhibition of FGFR Reactivates IFNgamma Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.
    Cancer Res. 2022;82:292-306.
    PubMed     Abstract available


    December 2021
  8. MA WK, Voss DM, Scharner J, Costa ASH, et al
    ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth.
    Cancer Res. 2021 Dec 17. pii: 0008-5472.CAN-20-0948.
    PubMed     Abstract available


  9. CHEN Y, Ling Z, Cai X, Xu Y, et al
    Activation of YAP1 by N6-methyladenosine-modified CircCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Cancer Res. 2021 Dec 16. pii: 0008-5472.CAN-21-1628.
    PubMed     Abstract available


  10. XU F, Tong M, Tong CSW, Chan BKC, et al
    A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.
    Cancer Res. 2021;81:6219-6232.
    PubMed     Abstract available


  11. BELLIDO MOLIAS F, Sim A, Leong KW, An O, et al
    Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer.
    Cancer Res. 2021;81:5849-5861.
    PubMed     Abstract available


    November 2021
  12. PEASE DR, Fernandez-Zapico ME
    mTOR-Dependent ARID1A Degradation: A New Twist in the Genetic-Epigenetic Interplay Driving Hepatocellular Carcinoma.
    Cancer Res. 2021;81:5608-5610.
    PubMed     Abstract available


  13. REN X, Rong Z, Liu X, Gao J, et al
    The protein kinase activity of NME7 activates Wnt/beta-Catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma.
    Cancer Res. 2021 Nov 11. pii: 0008-5472.CAN-21-1020.
    PubMed     Abstract available


  14. SENDI H, Yazdimamaghani M, Hu M, Sultanpuram N, et al
    Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis.
    Cancer Res. 2021 Nov 9. pii: 0008-5472.CAN-21-2269.
    PubMed     Abstract available


    October 2021
  15. BARCENA-VARELA M, Lujambio A
    A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma.
    Cancer Res. 2021;81:4899-4900.
    PubMed     Abstract available


    September 2021
  16. LOH JJ, Li TW, Zhou L, Wong TL, et al
    FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness.
    Cancer Res. 2021 Sep 22. pii: 0008-5472.CAN-20-4226.
    PubMed     Abstract available


  17. KAN X, Zhou G, Zhang F, Ji H, et al
    Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection.
    Cancer Res. 2021;81:4594-4602.
    PubMed     Abstract available


    August 2021
  18. ZHANG S, Zhou YF, Cao J, Burley SK, et al
    mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
    Cancer Res. 2021 Aug 24. pii: 0008-5472.CAN-21-0206.
    PubMed     Abstract available


    July 2021
  19. UNFRIED JP, Marin-Baquero M, Rivera-Calzada A, Razquin N, et al
    Long noncoding RNA NIHCOLE promotes ligation efficiency of DNA double-strand breaks in hepatocellular carcinoma.
    Cancer Res. 2021 Jul 28. pii: 0008-5472.CAN-21-0463.
    PubMed     Abstract available


  20. QIU X, Yang S, Wang S, Wu J, et al
    M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.
    Cancer Res. 2021 Jul 23. pii: 0008-5472.CAN-21-0468.
    PubMed     Abstract available


  21. TANG M, Yang M, Wu G, Mo S, et al
    Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer-Initiating Cells.
    Cancer Res. 2021;81:3835-3848.
    PubMed     Abstract available


  22. PARK M, Kim JW, Kim KM, Kang S, et al
    Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance.
    Cancer Res. 2021;81:3539-3553.
    PubMed     Abstract available


    June 2021
  23. SHRIKI A, Lanton T, Sonnenblick A, Levkovitch-Siany O, et al
    Multiple Roles of IL-6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis.
    Cancer Res. 2021 Jun 11. pii: 0008-5472.CAN-21-0321.
    PubMed     Abstract available


  24. GONZALEZ-ROMERO F, Mestre D, Aurrekoetxea I, O'Rourke CJ, et al
    E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
    Cancer Res. 2021;81:2874-2887.
    PubMed     Abstract available


  25. LULLI M, Del Coco L, Mello T, Sukowati C, et al
    DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer.
    Cancer Res. 2021;81:2861-2873.
    PubMed     Abstract available


    May 2021
  26. ZHAO Z, Gad H, Benitez-Buelga C, Sanjiv K, et al
    NEIL3 prevents senescence in hepatocellular carcinoma by repairing oxidative lesions at telomeres during mitosis.
    Cancer Res. 2021 May 27. pii: 0008-5472.CAN-20-1028.
    PubMed     Abstract available


  27. MA APY, Yeung CLS, Tey SK, Mao X, et al
    Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant Cav1/SREBP-1 signaling.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-3944.
    PubMed     Abstract available


    April 2021
  28. LEUNG HW, Leung CO, Lau EY, Chung KPS, et al
    EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0184.
    PubMed     Abstract available


  29. DU L, Li Y, Kang M, Feng M, et al
    USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-20-4163.
    PubMed     Abstract available


  30. RICCIOTTI E, Wangensteen KJ, FitzGerald GA
    Aspirin in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 23. pii: 0008-5472.CAN-21-0758.
    PubMed     Abstract available


  31. FUHRMAN BJ, Moore SC, Byrne C, Makhoul I, et al
    Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.
    Cancer Res. 2021;81:2246-2255.
    PubMed     Abstract available


  32. BROADFIELD LA, Duarte JAG, Schmieder R, Broekaert D, et al
    Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis.
    Cancer Res. 2021;81:1988-2001.
    PubMed     Abstract available


    March 2021
  33. ZHANG C, Gao Y, Du C, Markowitz GJ, et al
    Hepatitis B-induced IL-8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation.
    Cancer Res. 2021 Mar 2. pii: 0008-5472.CAN-20-3453.
    PubMed     Abstract available


    February 2021
  34. MENG Y, Zhao Q, An L, Jiao S, et al
    A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP signaling in hepatic progenitor cells.
    Cancer Res. 2021 Feb 22. pii: 0008-5472.CAN-20-3175.
    PubMed     Abstract available


  35. BI L, Ren Y, Feng M, Meng P, et al
    HDAC11 regulates glycolysis through the LKB1/AMPK signaling pathway to maintain hepatocellular carcinoma stemness.
    Cancer Res. 2021 Feb 18. pii: 0008-5472.CAN-20-3044.
    PubMed     Abstract available


  36. ZHOU J, Li Q, Cao Y
    Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer.
    Cancer Res. 2021 Feb 15. pii: 0008-5472.CAN-20-3665.
    PubMed     Abstract available


  37. DAVENPORT ML, Echols JB, Silva AD, Anderson JC, et al
    miR-31 displays subtype specificity in lung cancer.
    Cancer Res. 2021 Feb 8. pii: 0008-5472.CAN-20-2769.
    PubMed     Abstract available


    January 2021
  38. YAMADA K, Oikawa T, Kizawa R, Motohashi S, et al
    Unconventional Secretion of PKCdelta Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
    Cancer Res. 2021;81:414-425.
    PubMed     Abstract available


  39. HONG SH, Son KH, Ha SY, Wee TI, et al
    Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Cancer Res. 2021;81:356-370.
    PubMed     Abstract available


  40. GENG Y, Fan J, Chen L, Zhang C, et al
    A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis.
    Cancer Res. 2021;81:64-76.
    PubMed     Abstract available


  41. BATTISTELLI C, Garbo S, Riccioni V, Montaldo C, et al
    Design and Functional Validation of a Mutant Variant of the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2021;81:103-113.
    PubMed     Abstract available


    December 2020
  42. CAI LY, Chen SJ, Xiao SH, Sun QJ, et al
    Targeting p300/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism.
    Cancer Res. 2020 Dec 23. pii: 0008-5472.CAN-20-1323.
    PubMed     Abstract available


  43. ZHOU Q, Tian W, Jiang Z, Huang T, et al
    A positive feedback loop of AKR1C3-mediated activation of NF-kappaB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma.
    Cancer Res. 2020 Dec 23. pii: 0008-5472.CAN-20-2480.
    PubMed     Abstract available


  44. FEI F, Sun S, Li Q, Pei Z, et al
    Combinatorial normalization of liver-derived cytokine pathways alleviates hepatic tumor-associated cachexia in zebrafish.
    Cancer Res. 2020 Dec 21. pii: 0008-5472.CAN-20-2818.
    PubMed     Abstract available


  45. THOMANN S, Weiler SME, Marquard S, Rose F, et al
    YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
    Cancer Res. 2020;80:5502-5514.
    PubMed     Abstract available


    October 2020
  46. WILLS CA, Liu X, Chen L, Zhao Y, et al
    Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis.
    Cancer Res. 2020 Oct 28. pii: 0008-5472.CAN-20-1976.
    PubMed     Abstract available


  47. MATSUMORI T, Kodama Y, Takai A, Shiokawa M, et al
    Hes1 is essential in proliferating ductal cell-mediated development of intrahepatic cholangiocarcinoma.
    Cancer Res. 2020 Oct 16. pii: 0008-5472.CAN-20-1161.
    PubMed     Abstract available


  48. MORITA T, Kodama Y, Shiokawa M, Kuriyama K, et al
    CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
    Cancer Res. 2020;80:4058-4070.
    PubMed     Abstract available


    August 2020
  49. UROSEVIC J, Blasco MT, Llorente A, Bellmunt A, et al
    ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer.
    Cancer Res. 2020 Aug 19. pii: 0008-5472.CAN-19-4028.
    PubMed     Abstract available


  50. LUO C, Liang J, Sharabi K, Hatting M, et al
    Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency.
    Cancer Res. 2020;80:3215-3221.
    PubMed     Abstract available


  51. ZHANG Y, Cedervall J, Hamidi A, Herre M, et al
    Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis.
    Cancer Res. 2020;80:3345-3358.
    PubMed     Abstract available


    July 2020
  52. MIDORIKAWA Y, Yamamoto S, Tatsuno K, Renard-Guillet C, et al
    Accumulation of molecular aberrations distinctive to hepatocellular carcinoma progression.
    Cancer Res. 2020 Jul 8. pii: 0008-5472.CAN-20-0225.
    PubMed     Abstract available


    June 2020
  53. YANG F, Wei Y, Han D, Li Y, et al
    Interaction with CD68 and regulation of GAS6 expression by endosialin in fibroblasts drives recruitment and polarization of macrophages in hepatocellular carcinoma.
    Cancer Res. 2020 Jun 26. pii: 0008-5472.CAN-19-2691.
    PubMed     Abstract available


    May 2020
  54. CHEN J, Mitra A, Li S, Song S, et al
    Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFbeta Signaling.
    Cancer Res. 2020;80:1819-1832.
    PubMed     Abstract available


    April 2020
  55. ZHANG L, Huo Q, Ge C, Zhao F, et al
    ZNF143-mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma.
    Cancer Res. 2020 Apr 20. pii: 0008-5472.CAN-19-3226.
    PubMed     Abstract available


    March 2020
  56. ZHU H, Yan F, Yuan T, Qian M, et al
    USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
    Cancer Res. 2020 Mar 26. pii: 0008-5472.CAN-19-2388.
    PubMed     Abstract available


  57. TAN S, Xu Y, Wang Z, Wang T, et al
    Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
    Cancer Res. 2020;80:1130-1142.
    PubMed     Abstract available


    February 2020
  58. SCHULIEN I, Hockenjos B, van Marck V, Ayata CK, et al
    Extracellular ATP and Purinergic P2Y2 Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage.
    Cancer Res. 2020;80:699-708.
    PubMed     Abstract available


  59. HEBERT JD, Myers SA, Naba A, Abbruzzese G, et al
    Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches.
    Cancer Res. 2020 Feb 4. pii: 0008-5472.CAN-19-2961.
    PubMed     Abstract available


  60. LIANG J, Zhao H, Diplas BH, Liu S, et al
    Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.
    Cancer Res. 2020;80:510-523.
    PubMed     Abstract available


    November 2019
  61. ZHOU J, Liu Y, Zhang Y, Li Q, et al
    Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer: a retrospective analysis.
    Cancer Res. 2019 Nov 1. pii: 0008-5472.CAN-19-1940.
    PubMed     Abstract available


    June 2019
  62. KAMAL Y, Schmit SL, Hoehn HJ, Amos CI, et al
    Transcriptomic differences between primary colorectal adenocarcinomas and distant metastases reveal metastatic colorectal cancer subtypes.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3945.
    PubMed     Abstract available


  63. WANG D, Fu L, Wei J, Xiong Y, et al
    PPARdelta mediates the effect of dietary fat in promoting colorectal cancer metastasis.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-19-0384.
    PubMed     Abstract available


    May 2019
  64. GORDON JA, Noble JW, Midha A, Derakhshan F, et al
    Upregulation of Scavenger receptor B1 is required for steroidogenic and non-steroidogenic cholesterol metabolism in prostate cancer.
    Cancer Res. 2019 May 7. pii: 0008-5472.CAN-18-2529.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: